Regeneron Pharmaceuticals
REGN
#376
Rank
โ‚น6.262 T
Marketcap
โ‚น59,736
Share price
2.06%
Change (1 day)
33.35%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚น458.22 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.91 Billion. In 2025 the company made an earning of โ‚น493.69 Billion, an increase over its 2024 earnings that were of โ‚น451.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น458.22 B-7.19%
2025 โ‚น493.69 B9.43%
2024 โ‚น451.15 B13.83%
2023 โ‚น396.35 B-13.57%
2022 โ‚น458.59 B-47.9%
2021 โ‚น880.21 B144.75%
2020 โ‚น359.64 B56.86%
2019 โ‚น229.27 B-4.87%
2018 โ‚น241.01 B22.86%
2017 โ‚น196.18 B56.3%
2016 โ‚น125.51 B8.55%
2015 โ‚น115.63 B54.53%
2014 โ‚น74.82 B11.14%
2013 โ‚น67.33 B72.13%
2012 โ‚น39.11 B-285.93%
2011 -โ‚น21.04 Billion121.73%
2010 -โ‚น9.49 Billion37.18%
2009 -โ‚น6.92 Billion-14.6%
2008 -โ‚น8.1 Billion-25.02%
2007 -โ‚น10.81 Billion6.32%
2006 -โ‚น10.17 Billion-186.52%
2005 โ‚น11.74 B2103.7%
2004 โ‚น0.53 B-105.66%
2003 -โ‚น9.42 Billion-18.18%
2002 -โ‚น11.52 Billion42.33%
2001 -โ‚น8.09 Billion129.35%
2000 -โ‚น3.53 Billion51.87%
1999 -โ‚น2.33 Billion92.19%
1998 -โ‚น1.21 Billion66.23%
1997 -โ‚น0.73 Billion-55.49%
1996 -โ‚น1.64 Billion103.53%
1995 -โ‚น0.81 Billion-70.89%
1994 -โ‚น2.76 Billion-26.08%
1993 -โ‚น3.73 Billion114.67%
1992 -โ‚น1.74 Billion196.77%
1991 -โ‚น0.59 Billion87.88%
1990 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.452 T 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.489 T 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น857.67 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น722.84 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น153.18 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.08 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA